Wall Street analyst sets SpaceX (SPCX) stock price target for 12 months

Space Exploration Technologies Corp. (NASDAQ: SPCX) traded above its IPO price for 30 consecutive days through September 21, 2026. Morgan Stanley analyst Adam Jonas expects the stock to rally to a new all-time high over the next 12 months, signaling a constructive post-IPO outlook.

Analysis

The 30-day post-IPO-price signal is more relevant to market structure than intrinsic value: it can attract momentum mandates and reduce near-term underwater-holder supply, but it does not establish a durable earnings or cash-flow re-rating. The key question is whether SPCX's public float remains constrained relative to demand; if so, analyst-driven upside targets can amplify a squeeze, while any secondary offering, insider lockup expiration, or early investor distribution would quickly remove that technical support. Morgan Stanley's incentive and potential underwriting relationship should be treated as a reason to verify, not extrapolate, the call.

Near term, SPCX can outperform aerospace peers if incremental contracts, launch cadence disclosures, or government awards validate a revenue-growth narrative. Over 1-3 months, the more consequential catalyst is the first public earnings/guidance cycle: investors need visibility on launch economics, capex intensity, backlog conversion, and the cash required to fund non-core projects. The contrarian view is that a sustained premium to IPO price may already be pricing scarcity and narrative rather than fundamentals; a miss on cadence or a capital raise could compress the multiple faster than it affects long-duration operational value. MS has only indirect upside through trading, financing, and potential advisory economics, unlikely to be material to its earnings.

Key Decisions for Investors

• Do not initiate a fundamental SPCX long solely on the technical milestone; establish an alert for the first earnings release and require evidence of backlog conversion, positive unit-economics trend, and liquidity runway before underwriting a 6-18 month position.
• For a tactical 1-3 month momentum trade, buy SPCX only on a high-volume breakout above the post-IPO range with a defined stop at the IPO price; size small because float, lockup, and secondary-offering data are missing. Target a 15-20% move, risking 7-10%.
• If SPCX rallies materially ahead of its first detailed financial disclosure, consider a relative-value hedge: long RKLB versus short SPCX only after confirming comparable business exposure and borrow availability. The thesis is that disclosed revenue/cash-flow visibility should command a premium over a scarcity-driven valuation; exit if SPCX provides superior margin or backlog disclosures.
• Monitor SEC filings for lockup expiration, resale registrations, and any shelf or secondary issuance. A new supply event is the clearest falsifier of the near-term technical-bull thesis and would favor reducing tactical exposure immediately.
• Maintain no directional position in MS on this development; reassess only if capital-markets activity around SPCX becomes large enough to affect quarterly investment-banking or trading commentary.